1. Home
  2. GATX vs CYTK Comparison

GATX vs CYTK Comparison

Compare GATX & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GATX
  • CYTK
  • Stock Information
  • Founded
  • GATX 1898
  • CYTK 1997
  • Country
  • GATX United States
  • CYTK United States
  • Employees
  • GATX N/A
  • CYTK N/A
  • Industry
  • GATX Transportation Services
  • CYTK Biotechnology: Pharmaceutical Preparations
  • Sector
  • GATX Consumer Discretionary
  • CYTK Health Care
  • Exchange
  • GATX Nasdaq
  • CYTK Nasdaq
  • Market Cap
  • GATX 5.6B
  • CYTK 5.6B
  • IPO Year
  • GATX N/A
  • CYTK 2004
  • Fundamental
  • Price
  • GATX $155.21
  • CYTK $40.19
  • Analyst Decision
  • GATX Buy
  • CYTK Strong Buy
  • Analyst Count
  • GATX 2
  • CYTK 17
  • Target Price
  • GATX $162.50
  • CYTK $82.00
  • AVG Volume (30 Days)
  • GATX 150.0K
  • CYTK 1.6M
  • Earning Date
  • GATX 04-22-2025
  • CYTK 05-07-2025
  • Dividend Yield
  • GATX 1.57%
  • CYTK N/A
  • EPS Growth
  • GATX 9.27
  • CYTK N/A
  • EPS
  • GATX 7.78
  • CYTK N/A
  • Revenue
  • GATX $1,585,500,000.00
  • CYTK $18,474,000.00
  • Revenue This Year
  • GATX $10.19
  • CYTK $55.82
  • Revenue Next Year
  • GATX $5.72
  • CYTK $683.10
  • P/E Ratio
  • GATX $19.96
  • CYTK N/A
  • Revenue Growth
  • GATX 12.38
  • CYTK 145.34
  • 52 Week Low
  • GATX $122.00
  • CYTK $39.81
  • 52 Week High
  • GATX $168.89
  • CYTK $75.71
  • Technical
  • Relative Strength Index (RSI)
  • GATX 44.46
  • CYTK 35.75
  • Support Level
  • GATX $152.66
  • CYTK $42.66
  • Resistance Level
  • GATX $160.29
  • CYTK $48.43
  • Average True Range (ATR)
  • GATX 3.01
  • CYTK 2.04
  • MACD
  • GATX 0.39
  • CYTK -0.21
  • Stochastic Oscillator
  • GATX 53.26
  • CYTK 4.41

About GATX GATX Corporation

GATX Corp is a provider of railcar leasing and maintenance services. GATX operates in business segments including rail North America, rail international, Engine Leasing, and others. The rail business offers railcar leasing and maintenance, as well as asset-related, financial, and management services. The company owns and leases fleets in North America, Europe, and Asia, which consist of tank and freight railcars. Industries served include refining and petroleum, chemicals and plastics, railroads and other transportation, mining, and food and agriculture.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: